Compare · CELZ vs COIN
CELZ vs COIN
Side-by-side comparison of Creative Medical Technology Holdings Inc. (CELZ) and Coinbase Global Inc. (COIN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELZ and COIN operate in Finance: Consumer Services (Finance), so they compete in similar markets.
- COIN is the larger of the two at $49.38B, about 6040.5x CELZ ($8.2M).
- COIN has been more active in the news (13 items in the past 4 weeks vs 5 for CELZ).
- COIN has more recent analyst coverage (25 ratings vs 1 for CELZ).
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
Coinbase Global Inc.
Coinbase Global, Inc. provides financial infrastructure and technology for the cryptoeconomy. The company provides primary financial account for the cryptoeconomy, a platform to invest, store, spend, earn, and use crypto assets; an online marketplace for hedge funds, money managers, and corporations; and a platform with technology and services to developers, merchants, and asset issuers that enables them to build applications that leverage crypto protocols. It serves retail users, institutions, and ecosystem partners. The company was founded in 2012 and is based in Wilmington, Delaware.
Latest CELZ
- Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning
- SEC Form 10-Q filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms
- SEC Form 424B3 filed by Creative Medical Technology Holdings Inc.
- SEC Form EFFECT filed by Creative Medical Technology Holdings Inc.
- SEC Form S-3 filed by Creative Medical Technology Holdings Inc.
- SEC Form DEF 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- SEC Form PRE 14A filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings Issues Mid-Year Update
Latest COIN
- Chief Accounting Officer Jones Jennifer N. converted options into 4,564 shares and covered exercise/tax liability with 2,502 shares (SEC Form 4) to satisfy withholding obligation
- President & COO Choi Emilie converted options into 36,376 shares and covered exercise/tax liability with 18,037 shares, increasing direct ownership by 3% to 568,122 units (SEC Form 4) to satisfy withholding tax
- Director Davies Christa converted options into 748 shares and covered exercise/tax liability with 57 shares, increasing direct ownership by 22% to 3,770 units (SEC Form 4) (for withholding tax)
- Director Lehane Chris converted options into 748 shares, increasing direct ownership by 25% to 3,776 units (SEC Form 4)
- Chief Financial Officer Haas Alesia J converted options into 16,817 shares and covered exercise/tax liability with 8,339 shares, increasing direct ownership by 2% to 384,406 units (SEC Form 4) (tax liability)
- Coinbase Selects Chainlink To Bring New Tokenized Stocks to Millions of DeFi Users
- Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.85 Million Tokens, and Total Crypto and Total Cash Holdings of $14.9 Billion
- SEC Form 4 filed by President & COO Choi Emilie
- SEC Form 4 filed by Chief People Officer Brock Lawrence J
- Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.82 Million Tokens, and Total Crypto and Total Cash Holdings of $11.4 Billion